|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2001-5-31
|
|
pubmed:abstractText |
To estimate the cost effectiveness of treatment with n-3 polyunsaturated fatty acids (PUFA) for secondary prevention after myocardial infarction (MI).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
T
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1170-7690
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
411-20
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11383757-Cost-Benefit Analysis,
pubmed-meshheading:11383757-Economics, Pharmaceutical,
pubmed-meshheading:11383757-Fatty Acids, Omega-3,
pubmed-meshheading:11383757-Humans,
pubmed-meshheading:11383757-Insurance, Health, Reimbursement,
pubmed-meshheading:11383757-Italy,
pubmed-meshheading:11383757-Myocardial Infarction,
pubmed-meshheading:11383757-Prospective Studies
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Cost-effectiveness analysis of n-3 polyunsaturated fatty acids (PUFA) after myocardial infarction: results from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-Prevenzione Trial.
|
|
pubmed:affiliation |
Department of Cardiovascular Research, Istituto di Richerche Farmacologiche Mario Negri, Milano, Italy. franzosi@marionegri.it
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
